发明名称 |
Combined treatment of multiple sclerosis |
摘要 |
The use of growth hormone (GH) together with an interferon (IFN) to produce a pharmaceutical composition for treating multiple sclerosis and/or other demyelinating diseases is disclosed. Disclosed are also pharmaceutical compositions for treating multiple sclerosis and/or other demyelinating diseases. Disclosed are also pharmaceutical compositions for the simultaneous, separate or sequential use of its active ingredients for the above specified therapy. In particular, the advantage of EP0003504 of GH together with IFN-beta to produce a pharmaceutical composition for the treatment of multiple sclerosis are shown.
|
申请公布号 |
US6869600(B1) |
申请公布日期 |
2005.03.22 |
申请号 |
US20010958351 |
申请日期 |
2001.12.20 |
申请人 |
APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. |
发明人 |
SADOUL REMY;PAGLIUSI SONIA |
分类号 |
A61K38/21;A61K38/27;A61P25/00;(IPC1-7):A61K38/00;C07K14/565;C07K14/575;C07K14/61 |
主分类号 |
A61K38/21 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|